Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 75
Filter
1.
Braz. j. med. biol. res ; 54(9): e10931, 2021. tab, graf
Article in English | LILACS | ID: biblio-1249340

ABSTRACT

Tobacco can induce reactive oxygen species (ROS) production extensively in cells, which is a major risk factor for oral leukoplakia (OLK) development. Peroxiredoxin 1 (Prx1) is a key antioxidant protein, upregulated in a variety of malignant tumors. We previously found that nicotine, the main ingredient of tobacco, promotes oral carcinogenesis via regulating Prx1. The aim of the present study was to screen and identify the Prx1 interacting proteins and investigate the mechanisms of nicotine on the development of OLK. Through liquid chromatography-tandem mass spectrometry combined with bioinformatics analysis, the candidate Prx1 interacting proteins of cofilin-1 (CFL1), tropomyosin alpha-3 chain (TPM3), and serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform (PPP2R1A) were screened in human dysplastic oral keratinocyte cells treated with nicotine. CFL1, TPM3, and PPP2R1A were highly expressed in human OLK tissues. The expression of CFL1 increased and the expression of PPP2R1A decreased in OLK of smokers compared to that in OLK of non-smokers. Nicotine upregulated CFL1 and downregulated PPP2R1A in 4-nitro-quinoline-1-oxide (4NQO)-induced OLK tissues in mice in part dependent on Prx1. Furthermore, the in-situ interaction of CFL1, TPM3, and PPP2R1A with Prx1 were validated in human OLK tissues. Our results suggested that tobacco might promote the development of OLK via regulating Prx1 and its interacting proteins CFL1 and PPP2R1A.


Subject(s)
Animals , Mice , Leukoplakia, Oral/chemically induced , Peroxiredoxins/metabolism , Nicotine , Carrier Proteins , Homeodomain Proteins , Carcinogenesis
2.
National Journal of Andrology ; (12): 926-933, 2020.
Article in Chinese | WPRIM | ID: wpr-880294

ABSTRACT

Objective@#To investigate the relationship of electromagnetic radiation (EMR) from 900 MHz cellphone frequency with testicular oxidative damage and its influence on the Prdx2 protein expression in the rat testis, and to explore the mechanism of Guilingji Capsules (GC) alleviating oxidative damage to the testis tissue.@*METHODS@#Fifty healthy SD male rats were randomly divided into five groups of equal number, sham-EMR, 4-h EMR, 8-h EMR, 4-h EMR+GC and 8-h EMR+GC and exposed to 900 MHz EMR (370 μW/cm2) for 0, 4 or 8 hours daily for 15 successive days. The rats of the latter two groups were treated intragastrically with GC suspension and those of the first three groups with pure water after exposure to EMR each day. After 15 days of exposure and treatment, all the rats were sacrificed and their testis tissue collected for observation of the histomorphological and ultrastructural changes by HE staining and transmission electron microscopy, measurement of the levels of serum glutathione (GSH), superoxide dismutase (SOD) and malondialdehyde (MDA) with thiobarbiuric acid and determination of the Prdx2 protein expression by immunohistochemistry and Western blot.@*RESULTS@#Compared with the rats in the sham-EMR group, those in the 4-h and 8-h EMR groups showed different degrees of histomorphological and ultrastructural changes in the testis tissue, significantly decreased levels of GSH ([80.62 ± 10.99] vs [69.58 ± 4.18] and [66.17 ± 8.45] mg/L, P < 0.05) and SOD ([172.29 ± 10.98] vs [158.92 ± 6.46] and [148.91 ± 8.60] U/ml, P < 0.05) and increased level of MDA ([7.51 ± 1.73] vs [9.84 ± 1.03] and [11.22 ± 2.13] umol/ml, P < 0.05), even more significantly in the 8-h than in the 4-h EMR group (P < 0.05). In comparison with the sham-EMR group, the expression of the Prdx2 protein was markedly downregulated in the 4-h and 8-h EMR groups (0.56 ± 0.03 vs 0.49 ± 0.03, 0.21 ± 0.01, P < 0.05), but again upregulated in the 4-h and 8-h EMR+GC groups (0.55±0.03 and 0.37±0.04) (P < 0.05).@*CONCLUSIONS@#Electromagnetic radiation from cellphones can cause ultrastructural damage to the testis tissue of male rats, while Guilingji Capsules can alleviate it, presumably by upregulating the Prdx2 protein expression in the testis tissue and reducing testicular oxidative damage.


Subject(s)
Animals , Male , Rats , Capsules , Cell Phone , Drugs, Chinese Herbal/therapeutic use , Electromagnetic Radiation , Glutathione/blood , Malondialdehyde/blood , Microscopy, Electron, Transmission , Oxidative Stress , Peroxiredoxins/metabolism , Radiation Injuries, Experimental/drug therapy , Superoxide Dismutase/blood , Testis/pathology , Thiobarbituric Acid Reactive Substances/analysis
3.
Laboratory Animal Research ; : 172-179, 2019.
Article in English | WPRIM | ID: wpr-786406

ABSTRACT

Glutamate leads to neuronal cell damage by generating neurotoxicity during brain development. The objective of this study is to identify proteins that differently expressed by glutamate treatment in neonatal cerebral cortex. Sprague-Dawley rat pups (post-natal day 7) were intraperitoneally injected with vehicle or glutamate (10 mg/kg). Brain tissues were isolated 4 h after drug treatment and fixed for morphological study. Moreover, cerebral cortices were collected for protein study. Two-dimensional gel electrophoresis and mass spectrometry were carried out to identify specific proteins. We observed severe histopathological changes in glutamate-exposed cerebral cortex. We identified various proteins that differentially expressed by glutamate exposure. Identified proteins were thioredoxin, peroxiredoxin 5, ubiquitin carboxy-terminal hydrolase L1, proteasome subunit alpha proteins, isocitrate dehydrogenase, and heat shock protein 60. Heat shock protein 60 was increased in glutamate exposed condition. However, other proteins were decreased in glutamate-treated animals. These proteins are related to anti-oxidant, protein degradation, metabolism, signal transduction, and anti-apoptotic function. Thus, our findings can suggest that glutamate leads to neonatal cerebral cortex damage by regulation of specific proteins that mediated with various functions.


Subject(s)
Animals , Humans , Infant, Newborn , Rats , Brain , Cerebral Cortex , Chaperonin 60 , Electrophoresis, Gel, Two-Dimensional , Glutamic Acid , Isocitrate Dehydrogenase , Mass Spectrometry , Metabolism , Neurons , Peroxiredoxins , Proteasome Endopeptidase Complex , Proteolysis , Proteomics , Rats, Sprague-Dawley , Signal Transduction , Thioredoxins , Ubiquitin Thiolesterase
4.
Journal of Cancer Prevention ; : 65-71, 2019.
Article in English | WPRIM | ID: wpr-764308

ABSTRACT

Peroxiredoxins (Prxs) are antioxidant enzymes that protect cells from oxidative stress by reducing intracellular accumulation of reactive oxygen species (ROS). In mammalian cells, the six Prx isoforms are ubiquitously expressed in diverse intracellular locations. They are involved in the regulation of various physiological processes including cell growth, differentiation, apoptosis, immune response and metabolism as well as intracellular ROS homeostasis. Although there are increasing evidences that Prxs are involved in carcinogenesis of many cancers, their role in cancer is controversial. The ROS levels in cancer cells are increased compared to normal cells, thus promoting cancer development. Nevertheless, for various cancer types, an overexpression of Prxs has been found to be associated with poor patient prognosis, and an increasing number of studies have reported that tumorigenesis is either facilitated or inhibited by regulation of cancer-associated signaling pathways. This review summarizes Prx isoforms and their basic functions, the relationship between the expression level and the physiological role of Prxs in cancer cells, and their roles in regulating cancer-associated signaling pathways.


Subject(s)
Humans , Apoptosis , Carcinogenesis , Homeostasis , Metabolism , Oxidative Stress , Peroxiredoxins , Physiological Phenomena , Prognosis , Protein Isoforms , Reactive Oxygen Species
5.
Acta cir. bras ; 33(8): 703-712, Aug. 2018. tab, graf
Article in English | LILACS | ID: biblio-949375

ABSTRACT

Abstract Purpose: To assess the action of vitamin C on the expression of 84 oxidative stress related-genes in cultured skin fibroblasts from burn patients. Methods: Skin samples were obtained from ten burn patients. Human primary fibroblasts were isolated and cultured to be distributed into 2 groups: TF (n = 10, fibroblasts treated with vitamin C) and UF (n = 10, untreated fibroblasts). Gene expression analysis using quantitative polymerase chain reaction array was performed for comparisons between groups. Results: The comparison revealed 10 upregulated genes as follows: arachidonate 12-lipoxygenase (ALOX12), 24-dehydrocholesterol reductase (DHCR24), dual oxidase 1 (DUOX1), glutathione peroxidase 2 (GPX2), glutathione peroxidase 5 (GPX5), microsomal glutathione S-transferase 3 (MGST3), peroxiredoxin 4 (PRDX4), phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1 (P-REX1), prostaglandin-endoperoxide synthase 1 (PTGS1), and ring finger protein 7 (RNF7). Conclusion: Cultured fibroblasts obtained from burn patients and treated with vitamin C resulted in 10 differentially expressed genes, all overexpressed, with DUOX1, GPX5, GPX2 and PTGS1 being of most interest.


Subject(s)
Humans , Male , Female , Adult , Young Adult , Ascorbic Acid/pharmacology , Burns/pathology , Gene Expression/drug effects , Oxidative Stress/drug effects , Fibroblasts/drug effects , Fibroblasts/pathology , Reference Values , Skin/pathology , Arachidonate 12-Lipoxygenase/analysis , Arachidonate 12-Lipoxygenase/drug effects , Burns/drug therapy , Cells, Cultured , Cross-Sectional Studies , Statistics, Nonparametric , Ubiquitin-Protein Ligases/analysis , Oxidoreductases Acting on CH-CH Group Donors/analysis , Cyclooxygenase 1/analysis , Cyclooxygenase 1/drug effects , Peroxiredoxins/analysis , Real-Time Polymerase Chain Reaction , Dual Oxidases/analysis , Dual Oxidases/drug effects , Glutathione Peroxidase/analysis , Glutathione Peroxidase/drug effects
6.
Rev. Salusvita (Online) ; 36(4): 1169-1182, 2017.
Article in Portuguese | LILACS | ID: biblio-1022172

ABSTRACT

Introdução: uma variedade de estudos vem demonstrando que o laser de baixa potência estimula a osteogênese. Os mecanismos propostos para o efeito bioestimulador do laser envolvem aumento da síntese de ATP e formação de espécies reativas de oxigênio (EROs) pelas mitocôndrias. Estas EROs, incluindo peróxido de hidrogênio, atuam na sinalização celular e influenciam a regulação da expressão gênica, conduzindo a respostas celulares horas ou até mesmo dias após a irradiação. As Peroxirredoxinas (Prxs) constituem uma família de enzimas abundantes capazes de decompor peróxido de hidrogênio. Objetivo: foi realizada uma revisão de literatura acerca dos efeitos bioestimulantes do laser de baixa potência sobre o extresse oxidativo durante o processo de cicatrização. Material e Métodos: foi realizada uma busca nas bases de dados Pubmed e Scielo nos últimos anos, seguindo critérios de inclusão e exclusão pré-determinados, utilizando os termos peroxirredoxina, laser de baixa potência e osteoblastos. Resultados: foram identificados cinquenta artigos com texto completo que se enquadravam nos critérios de inclusão e exclusão. Quanto aos tipos de Peroxirredoxinas, se destacaram as Prxs I e IV. Conclusão: diante das informações colhidas na literatura, concluímos que o mecanismos de ação do laser, induz a formação de EROs, e ainda ressaltamos a importância do estabelecimento de parâmetros seguros na aplicação do laser para que os efeitos desejados, de bioestimulação, sejam alcançados e que sejam evitados os efeitos tóxicos.


Introduction: a variety of studies has shown that low-power laser stimulates osteogenesis. The mechanisms proposed for the biostimulating effect of the laser involve increased ATP synthesis and formation of reactive oxygen species (ROS) by mitochondria. These EROs, including hydrogen peroxide, act on cell signaling and influence the regulation of gene expression, leading to cellular responses at hours or even days after irradiation. Peroxiredoxins (Prxs) constitute a family of abundant enzymes capable of breaking down hydrogen peroxide. Objective: a literature review was carried out on the biostimulating effects of low power laser on oxidative stress during the cicatrization process. Material and Methods: a search of the PubMed and Scielo databases was carried out in recent years, following inclusion and exclusion criteria, using as descriptors peroxirredoxin, low power laser and osteoblasts. Results: fifty full-text articles were identified that fit the inclusion and exclusion criteria. As for the types of Peroxirredoxins, Prxs I and IV were highlighted. Conclusion: In light of the information gathered in the literature, we conclude that the mechanisms of action of the laser induce the formation of EROs, and we also stress the importance of establishing safe parameters in the laser application so that the desired effects of biostimulation are achieved and that toxic effects are avoided.


Subject(s)
Peroxiredoxins , Osteoblasts , Low-Level Light Therapy
7.
São Paulo; s.n; s.n; 2017. 58 p. tab, graf, ilus.
Thesis in Portuguese | LILACS | ID: biblio-1361660

ABSTRACT

As peroxirredoxinas (Prx) são enzimas antioxidantes que se destacam pela capacidade de decompor uma grande variedade de hidroperóxidos com elevada eficiência (106-108M-1s-1), mantendo essas moléculas em níveis adequados à homeostase celular. Entretanto, já foi demonstrado que em diversos tipos tumorais os níveis de Prx são extremamente aumentados e experimentos envolvendo sua inativação resultam na diferenciação ou apoptose de células tumorais. Recentemente, foi descoberto um diterpenóide denominado adenantina que seria o primeiro inibidor para as Prx1 e Prx2 de humanos e foi demonstrada que sua aplicação em células de leucemia mieloide aguda promoveu diferenciação ou apoptose dessas células. Nesse contexto, o presente trabalho apresenta duas vertentes: 1) A caracterização das alterações estruturais e funcionais promovidas pela ligação da adenantina ao sítio ativo das Prx utilizando Tsa1 de Saccharomyces cerevisiae como modelo biológico, em função da sua alta similaridade com Prx2 de humanos; 2) Avaliação da atividade antitumoral dose dependente de adenantina sobre as linhagens celulares REH e MOLT-4 de leucemia linfoide aguda. No que concerne à primeira linha de investigação, nossos resultados revelam que Tsa1 é suscetível à inibição por adenantina, uma vez que o tratamento reduziu em ~66 % a velocidade de decomposição de peróxido de hidrogênio. Adicionalmente, a mutação da Thr44 de Tsa1, pertencente à chamada tríade catalítica, por uma Ser resultou em uma proteína mais suscetível a alterações na estrutura secundária e à inibição da atividade peroxidásica em função da ligação com adenantina, apresentando uma diminuição de ~85% na velocidade de reação. Características semelhantes foram observadas para a proteoforma Tsa2 de S. cerevisiae, que carreia naturalmente a substituição da Thr44 pela Ser. Análises de sequências de Prx em bancos de dados revelaram que majoritariamente proteínas contendo Ser são encontradas em organismos procariotos, muitos deles patogênicos. Finalmente, demonstramos por meio de ensaios citotoxicidade que as bactérias Staphylococcus aureus e Staphylococcus epidermidis, que possuem uma Ser na tríade catalítica, têm seu crescimento inibido pelo tratamento com adenantina (IC50 de 460µM e 77µM, respectivamente), enquanto que para Escherichia coli, que possui Thr nessa posição, a toxicidade da adenantina foi bastante baixa (não foi possível determinar o IC50 nas condições utilizadas). Dessa forma, os dados apresentados neste trabalho demonstram o potencial da utilização da adenantina tanto como antibiótico quanto como antileucêmico


Peroxiredoxins (Prx) are antioxidant enzymes which stand out due the ability to decompose a wide variety of hydroperoxides with high efficiency (106-108M-1s-1) maintaining these molecules at suitable levels to cellular homeostasis and participating in several signaling events. However, it has been shown that, in many tumor types, Prx levels are extremely increased and experiments involving its inactivation have resulted in differentiation or apoptosis of tumor cells. It was recently found a diterpenoid, called adenanthin, that would be the first human Prx1 and Prx2 inhibitor and it was demonstrated that its application in acute myeloid leukemia cells was able to promote differentiation or apoptosis. In this context, this work presents two lines of research: 1) Characterization of structural and functional changes promoted by adenanthin binding to Prx active site using Tsa1 from Saccharomyces cerevisiae as biological model, due to its high similarity to human Prx2. 2) Evaluation of adenanthin dose-dependent antitumor activity over the acute lymphoid leukemia cell lines REH and MOLT-4. As regards the first line of research, our result reveal that Tsa1 is susceptible to inhibition by adenanthin, since the treatment with this binder reduced the hydrogen peroxide decomposition velocity in ~ 66%. In addition, the replacement of Thr44 from Tsa1, aminoacid belonging to the so-called catalytic triad, by a Ser resulted in a protein more susceptible to alterations in secondary structure and to peroxidase activity inhibition in function of adenanthin binding, presenting ~85% of decrease in reaction velocity. Similar characteristics were observed for Tsa2 proteoform from S. cerevisiae, which naturally carries the substitution of Thr44 by Ser. Prx sequences analyzes in databases revealed that mostly Ser-containing proteins are found in prokaryotic organisms, many of them pathogenic ones. Finally, we demonstrate through cytotoxicity assays that the bacteria Staphylococcus aureus and Staphylococcus epidermidis, which have a Ser in catalytic triad, have their growth inhibited by adenanthin treatment (IC50 of 460µM and 77µM, respectively), whereas for Escherichia Coli, which has Thr at that position, the tocyxicity of adenanthin was quite low (it was not possible to determine the IC50 under the used conditions). Regarding the second line of investigation, we found that adenanthin is able to induce the death of leukemic cell lines REH and MOLT-4, and for the last one, there was an unexpected proliferation of cells treated by the longest incubation period (72 hours), characterizing a possible indication of differentiation process. In this sense, the data presented here demonstrate the potential of adenanthin use in both antibiotic and antileukemic treatment


Subject(s)
Saccharomyces cerevisiae/metabolism , Peroxiredoxins/classification , Growth Inhibitors/analysis , Leukemia, Myeloid, Acute/classification , Diterpenes/pharmacology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/classification , Anti-Bacterial Agents/pharmacology , Antioxidants/pharmacology
8.
Biomedical and Environmental Sciences ; (12): 224-228, 2017.
Article in English | WPRIM | ID: wpr-296493

ABSTRACT

4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) is a potent and prevalent nitrosamine procarcinogen found in cigarette smoke. The aim of this work is to study alterations in peroxiredoxin (Prx) expression induced by NNK during carcinogenesis. Characterization of Prx genes from hamster was performed using bioinformatics. V79 cells were induced with different concentrations of NNK (0.1-0.4 mg/mL), and the expression levels of six Prx genes (Prx1-Prx6) were measured by qRT-PCR 24 h following NNK treatment. Prx gene expression was induced by NNK stress, and the highest transcription levels were induced by over 20.42-fold relative to that of the control. NNK induced alterations in Prx expression over the course of lung cancer, which means Prxs may play important roles in ROS detoxification under NNK stress and their functions are complementary.


Subject(s)
Animals , Cricetinae , Carcinogens , Toxicity , Cell Line , Cell Survival , Cricetulus , Dose-Response Relationship, Drug , Gene Expression Regulation , Nitrosamines , Toxicity , Peroxiredoxins , Genetics , Metabolism
9.
Biomedical and Environmental Sciences ; (12): 584-588, 2016.
Article in English | WPRIM | ID: wpr-296565

ABSTRACT

Silicosis is one of the most serious occupational diseases in China and dates back to centuries ago. In this study, we successfully established a rat model of silicosis by intratracheal silica injection for 28 days and determined hydroxyproline levels to evaluate collagen metabolism in lung homogenates. Oxidative stress status was evaluated by detecting catalase and glutathione peroxidase activities. Expression levels of peroxiredoxins (Prx I and Prx VI) were detected by Western blotting. Pulmonary surfactant protein A (SP-A) levels in rat serum and lung tissue were analyzed by ELISA, and SP-A and Prx expression levels in lung tissues were detected by immunohistochemistry. The results suggest that Prx proteins may be involved in pulmonary fibrosis induced by silica. Downregulation of SP-A expression caused due to silica is an important factor in the occurrence and development of silicosis.


Subject(s)
Animals , Humans , Male , Rats , Disease Models, Animal , Lung , Metabolism , Oxidative Stress , Peroxiredoxin VI , Genetics , Metabolism , Peroxiredoxins , Genetics , Metabolism , Pulmonary Surfactant-Associated Protein A , Genetics , Metabolism , Silicon Dioxide , Toxicity , Silicosis , Genetics , Metabolism
10.
Experimental & Molecular Medicine ; : e165-2015.
Article in English | WPRIM | ID: wpr-142455

ABSTRACT

Redox adaptation is an important concept that explains the mechanisms by which cancer cells survive under persistent endogenous oxidative stress and become resistant to certain anticancer agents. To investigate this concept, we determined the expression levels of peroxiredoxins (Prxs), antioxidant enzymes in drug-resistant non-small cell lung carcinoma cells. Prx II was remarkably increased only in A549/GR (gefitinib-resistant) cells compared with A549 cells, consistent with methylation/demethylation. Prx II was highly methylated in the A549 cells but was demethylated in the A549/GR cells. The elevated expression of Prx II resulted in the downregulation of reactive oxygen species (ROS) and cell death and upregulation of cell cycle progression in the A549/GR cells. When Prx II mRNA in the A549/GR cells was knocked down, the levels of ROS and apoptosis were significantly recovered to the levels of the controls. In addition, signaling molecules involved in apoptosis were increased in the A549/GR-shPrx II cells. There was no difference in the expression of MAPK/ERK between the A549/GR cells and A549/GR-shPrx II cells, but the phosphorylation of JNK was increased in the A549/GR cells and was markedly decreased in the A549/GR-shPrx II cells. Colony number and tumor growth were significantly decreased in the A549/GR-shPrx II cells compared with the A549/GR cells. Our findings suggest that Prx II has an important role in cancer cell survival via the modulation of signaling molecules involved in apoptosis and the phosphorylation of JNK by the downregulation of ROS levels in A549/GR cells.


Subject(s)
Animals , Female , Humans , Antineoplastic Agents/therapeutic use , Apoptosis/drug effects , Carcinoma, Non-Small-Cell Lung/drug therapy , Cell Line, Tumor , Drug Resistance, Neoplasm , Lung/drug effects , Lung Neoplasms/drug therapy , Mice, Inbred BALB C , Mice, Nude , Oxidative Stress/drug effects , Peroxiredoxins/genetics , Quinazolines/therapeutic use , Reactive Oxygen Species/metabolism
11.
Experimental & Molecular Medicine ; : e165-2015.
Article in English | WPRIM | ID: wpr-142454

ABSTRACT

Redox adaptation is an important concept that explains the mechanisms by which cancer cells survive under persistent endogenous oxidative stress and become resistant to certain anticancer agents. To investigate this concept, we determined the expression levels of peroxiredoxins (Prxs), antioxidant enzymes in drug-resistant non-small cell lung carcinoma cells. Prx II was remarkably increased only in A549/GR (gefitinib-resistant) cells compared with A549 cells, consistent with methylation/demethylation. Prx II was highly methylated in the A549 cells but was demethylated in the A549/GR cells. The elevated expression of Prx II resulted in the downregulation of reactive oxygen species (ROS) and cell death and upregulation of cell cycle progression in the A549/GR cells. When Prx II mRNA in the A549/GR cells was knocked down, the levels of ROS and apoptosis were significantly recovered to the levels of the controls. In addition, signaling molecules involved in apoptosis were increased in the A549/GR-shPrx II cells. There was no difference in the expression of MAPK/ERK between the A549/GR cells and A549/GR-shPrx II cells, but the phosphorylation of JNK was increased in the A549/GR cells and was markedly decreased in the A549/GR-shPrx II cells. Colony number and tumor growth were significantly decreased in the A549/GR-shPrx II cells compared with the A549/GR cells. Our findings suggest that Prx II has an important role in cancer cell survival via the modulation of signaling molecules involved in apoptosis and the phosphorylation of JNK by the downregulation of ROS levels in A549/GR cells.


Subject(s)
Animals , Female , Humans , Antineoplastic Agents/therapeutic use , Apoptosis/drug effects , Carcinoma, Non-Small-Cell Lung/drug therapy , Cell Line, Tumor , Drug Resistance, Neoplasm , Lung/drug effects , Lung Neoplasms/drug therapy , Mice, Inbred BALB C , Mice, Nude , Oxidative Stress/drug effects , Peroxiredoxins/genetics , Quinazolines/therapeutic use , Reactive Oxygen Species/metabolism
12.
Journal of Central South University(Medical Sciences) ; (12): 842-848, 2014.
Article in Chinese | WPRIM | ID: wpr-815520

ABSTRACT

OBJECTIVE@#To explore the relationship between peroxiredoxin I expression and seminal reactive oxygen species (ROS) in patients with idiopathic asthenozoospermia.@*METHODS@#Twenty-six infertile male patients were selected from the Reproductive Medical Center, Xiangya Hospital, from September to December in 2012. Fresh semen was collected from an experimental group (26 idiopathic asthenozoospermia patients) and a control group (15 men with fertility history and normal semen). Luminol chemiluminescence method was applied to detect the seminal ROS level. Western blot was used to detect the peroxiredoxin I expression.@*RESULTS@#1)The seminal ROS level in the experimental group was significantly increased compared with that in the control group (P<0.05), and the seminal ROS level was negatively correlated with mobility of the sperm (r=-0.777, P<0.01). 2) Compared with the control group, the peroxiredoxin I expression was significantly downregulated in the experimental group (P<0.05). The content of sperm peroxiredoxin I in the 2 groups was negatively correlated with the seminal ROS level (r=-0.474, P<0.01). 3) The content of peroxiredoxin I had a positive correlation with human sperm motility(r=0.779, P<0.01).@*CONCLUSION@#The decline of peroxiredoxin I expression may be one of the crucial factors that leads to idiopathic asthenozoospermia. High level of ROS may be one of the main reasons for sperm vitality decline in patients with idiopathic asthenozoospermia.


Subject(s)
Humans , Male , Asthenozoospermia , Case-Control Studies , Peroxiredoxins , Metabolism , Reactive Oxygen Species , Chemistry , Semen , Chemistry , Sperm Motility , Spermatozoa , Metabolism
13.
Chinese Journal of Oncology ; (12): 5-10, 2014.
Article in Chinese | WPRIM | ID: wpr-329008

ABSTRACT

<p><b>OBJECTIVE</b>The aim of this study was to observe the effects of dioscin on apoptosis and on expression of PRDX1 in pancreatic cancer MiaPaCa-2 cells in vitro.</p><p><b>METHODS</b>MTT assay was used to detect the growth rate among the medication groups treated with different concentrations of dioscin. The apoptosis rate was determined by annexin V-fluorescein isothiocyanate/propidium iodide double staining and flow cytometry. Western blot analysis was used to assay the expression of PRDX1 and apoptotic proteins in the cells. Reactive oxygen species (ROS) formation was measured by 2'7'-dichlorofluorescein diacetate (DCFH-DA).</p><p><b>RESULTS</b>Dioscin considerably inhibited the proliferation of MiaPaCa-2 cells in vitro. The inhibitory action was enhanced in a dose-dependent manner. The levels of intracellular ROS detected with DCFH-DA were highly increased after dioscin treatment. The flow cytometry analysis using annexin V-PI staining showed that compared with the apoptotic rate of control group [(3.5 ± 0.7)%], 2.5 µmol/L and 5 µmol/L dioscin induced apoptosis in (28.4 ± 0.9)% and (49.6 ± 2.7)% MiaPaCa-2 cells, and Western blot analysis showed that apoptotic proteins Bax and cleaved caspase-3 expressions were increased and antiapoptotic protein Bcl-2 expression was decreased. In addition, these effects could be blocked by antioxidant N-acetylcysteine (NAC) administration, and the apoptotic rates decreased to (10.8 ± 2.3)% and (18.8 ± 3.0)%, respectively. We further observed the decrease of PRDX1 expression after dioscin treatment. Moreover, after PRDX1 overexpression, dioscin treatment no longer induced high levels of ROS and apoptosis, and the apoptotic rate was decreased to (21.3 ± 5.9)%.</p><p><b>CONCLUSION</b>Dioscin can down-regulate the PRDX1 expression, and then induces ROS-mediated apoptosis in cancer cells.</p>


Subject(s)
Humans , Apoptosis , Diosgenin , Pharmacology , Pancreatic Neoplasms , Pathology , Peroxiredoxins , Reactive Oxygen Species , Metabolism
14.
Mem. Inst. Oswaldo Cruz ; 108(6): 755-762, set. 2013. tab, graf
Article in English | LILACS | ID: lil-685485

ABSTRACT

Currently, several assays can confirm acute dengue infection at the point-of-care. However, none of these assays can predict the severity of the disease symptoms. A prognosis test that predicts the likelihood of a dengue patient to develop a severe form of the disease could permit more efficient patient triage and treatment. We hypothesise that mRNA expression of apoptosis and innate immune response-related genes will be differentially regulated during the early stages of dengue and might predict the clinical outcome. Aiming to identify biomarkers for dengue prognosis, we extracted mRNA from the peripheral blood mononuclear cells of mild and severe dengue patients during the febrile stage of the disease to measure the expression levels of selected genes by quantitative polymerase chain reaction. The selected candidate biomarkers were previously identified by our group as differentially expressed in microarray studies. We verified that the mRNA coding for CFD, MAGED1, PSMB9, PRDX4 and FCGR3B were differentially expressed between patients who developed clinical symptoms associated with the mild type of dengue and patients who showed clinical symptoms associated with severe dengue. We suggest that this gene expression panel could putatively serve as biomarkers for the clinical prognosis of dengue haemorrhagic fever.


Subject(s)
Humans , Antigens, Neoplasm/genetics , Cysteine Endopeptidases/genetics , Membrane Glycoproteins/genetics , Neoplasm Proteins/genetics , Peroxiredoxins/genetics , Receptors, IgG/genetics , Receptors, Interleukin-1/genetics , Severity of Illness Index , Severe Dengue/diagnosis , Apoptosis Regulatory Proteins/genetics , Biomarkers , Gene Expression , GPI-Linked Proteins/genetics , Immunity, Innate/genetics , Leukocytes, Mononuclear/immunology , Leukocytes, Mononuclear/pathology , Microarray Analysis , Prognosis , Real-Time Polymerase Chain Reaction , RNA, Messenger/isolation & purification , Serotyping
15.
Korean Journal of Pediatrics ; : 107-111, 2013.
Article in English | WPRIM | ID: wpr-208957

ABSTRACT

Preterm infants are vulnerable to the oxidative stress due to the production of large amounts of free radicals, antioxidant system insufficiency, and immature oligodendroglial cells. Reactive oxygen species (ROS) play a pivotal role in the development of periventricular leukomalacia. The three most common ROS are superoxide (O2*-), hydroxyl radical (OH*), and hydrogen peroxide (H2O2). Under normal physiological conditions, a balance is maintained between the production of ROS and the capacity of the antioxidant enzyme system. However, if this balance breaks down, ROS can exert toxic effects. Superoxide dismutase, glutathione peroxidase, and catalase are considered the classical antioxidant enzymes. A recently discovered antioxidant enzyme family, peroxiredoxin (Prdx), is also an important scavenger of free radicals. Prdx1 expression is induced at birth, whereas Prdx2 is constitutively expressed, and Prdx6 expression is consistent with the classical antioxidant enzymes. Several antioxidant substances have been studied as potential therapeutic agents; however, further preclinical and clinical studies are required before allowing clinical application.


Subject(s)
Humans , Infant, Newborn , Antioxidants , Brain , Brain Injuries , Catalase , Free Radicals , Glutathione Peroxidase , Hydrogen Peroxide , Hydroxyl Radical , Infant, Premature , Leukomalacia, Periventricular , Oxidative Stress , Parturition , Peroxiredoxins , Reactive Oxygen Species , Superoxide Dismutase , Superoxides
16.
Hanyang Medical Reviews ; : 97-103, 2013.
Article in Korean | WPRIM | ID: wpr-86605

ABSTRACT

Peroxiredoxins (Prxs) are a family of antioxidant proteins that reduce peroxide levels by using reducing agents such as thioredoxin. These proteins were characterized to have a number of cellular functions, including cell proliferation and differentiation and protection of specific proteins from oxidative damage. Thus, it is important to clarify the physiological role of Prxs by generating mouse models deficient in each Prx to better understand the in vivo function of Prxs. We have generated and characterized mice deficient in Prx I and II that are abundantly expressed in almost all types of cells. The Prx II-/- mice were healthy in appearance and fertile, however showed several pathophysiological disorders. Using the mice, we found that Prx II is an essential antioxidant enzyme that prevents oxidative stress in erythropoiesis, protects against endotoxin-induced lethal shock, regulates platelet-derived growth factor signaling and angiogenesis, inhibits cellular senescence, preserves cognitive function against age-linked hippocampal oxidative damage and exacerbates tumorigenesis in a liver cancer mouse model. The Prx I-/- mice were also healthy in appearance and fertile like Prx II-/- mice. With the mice, we found that Prx I suppresses K-ras-driven lung tumorigenesis by opposing the redox-sensitive extracellular-signal-regulated kinase/cyclin D1 pathway and plays concerted action with sulfiredoxin in preventing against alcohol-induced oxidative injury in the mouse liver. The results obtained suggest that Prx I and II are essential antioxidant enzymes for maintaining redox homeostasis in mice.


Subject(s)
Animals , Humans , Mice , Antioxidants , Cellular Senescence , Cell Proliferation , Cell Transformation, Neoplastic , Erythropoiesis , Homeostasis , Liver , Liver Neoplasms , Lung , Mice, Knockout , Oxidation-Reduction , Oxidative Stress , Peroxiredoxins , Platelet-Derived Growth Factor , Proteins , Reducing Agents , Shock , Thioredoxins
17.
Tuberculosis and Respiratory Diseases ; : 59-66, 2013.
Article in English | WPRIM | ID: wpr-77371

ABSTRACT

BACKGROUND: This study was conducted in order to elucidate the effects of docetaxel on the growth of peroxiredoxin 1 (Prx1) knockdown A549 xenograft tumors and further tested the role of Prx1 as a predictor for how a patient would respond to docetaxel treatment. METHODS: Effects of docetaxel on the growth of scrambled- and shPrx1-infected A549 xenograft tumors in nude mice were measured. Moreover, immunohistochemical expression of Prx1 was evaluated in paraffin-embedded tissues from 24 non-small cell lung cancer patients who had received docetaxel-cisplatin regimens as a first-line treatment. RESULTS: Docetaxel treatment in Prx1 knockdown xenograft tumor resulted in reduced tumors growth compared with other groups. Prx1 knockdown increased the production of cleaved caspases-8 and -9 in the control itself compared to scramble tumors. Moreover, docetaxel treatment in Prx1 knockdown tissue led to an increased protein band. Phosphorylated Akt was found in Prx1 scramble tissues. Phosphorylated FOXO1 was detected in the docetaxel treatment group. On the other hand, Prx1 knockdown completely suppressed the Akt-FOXO1 axis. The median progression-free survival (PFS) of patients with low Prx1 expression was 7 months (95% confidence interval [CI], 6.0-7.7), whereas the median progression-free survival of patients with high Prx1 expression was 4 months (95% CI, 4.0-5.0). However, high Prx1 expression was not associated with decreased PFS (p=0.114). CONCLUSION: Our findings suggest that elevated Prx1 provides resistance to docetaxel treatment through suppression of FOXO1-induced apoptosis in A549 xenograft tumors, but may not be related with the predictive significance for response to docetaxel treatment.


Subject(s)
Animals , Humans , Mice , Apoptosis , Axis, Cervical Vertebra , Carcinoma, Non-Small-Cell Lung , Disease-Free Survival , Hand , Lung , Lung Neoplasms , Mice, Nude , Peroxiredoxins , Taxoids , Transplantation, Heterologous
18.
Biomolecules & Therapeutics ; : 89-96, 2013.
Article in English | WPRIM | ID: wpr-201026

ABSTRACT

Atherosclerotic vascular dysfunction is a chronic inflammatory process that spreads from the fatty streak and foam cells through lesion progression. Therefore, its early diagnosis and prevention is unfeasible. Reactive oxygen species (ROS) play important roles in the pathogenesis of atherosclerotic vascular disease. Intracellular redox status is tightly regulated by oxidant and antioxidant systems. Imbalance in these systems causes oxidative or reductive stress which triggers cellular damage or aberrant signaling, and leads to dysregulation. Paradoxically, large clinical trials have shown that non-specific ROS scavenging by antioxidant vitamins is ineffective or sometimes harmful. ROS production can be locally regulated by cellular antioxidant enzymes, such as superoxide dismutases, catalase, glutathione peroxidases and peroxiredoxins. Therapeutic approach targeting these antioxidant enzymes might prove beneficial for prevention of ROS-related atherosclerotic vascular disease. Conversely, the development of specific antioxidant enzyme-mimetics could contribute to the clinical effectiveness.


Subject(s)
Atherosclerosis , Catalase , Early Diagnosis , Foam Cells , Glutathione , Oxidation-Reduction , Peroxidases , Peroxiredoxins , Reactive Oxygen Species , Superoxides , Vascular Diseases , Vitamins
19.
Chinese Journal of Industrial Hygiene and Occupational Diseases ; (12): 531-533, 2013.
Article in Chinese | WPRIM | ID: wpr-275897

ABSTRACT

<p><b>OBJECTIVE</b>To evaluate the change in protein expression of peroxiredoxin I (Prx I) during pulmonary fibrosis among rats exposed to silica dust and to investigate the role of Prx I in pulmonary fibrosis.</p><p><b>METHODS</b>Ninety male Wistar rats were randomly divided into control group (n = 60) and experimental group (n = 30). The control group received intratracheal perfusion of saline (1 ml), while the experimental group received intratracheal perfusion of suspension of silica dust (50 mg/ml) to establish a rat model of silicosis. At 1, 2, 3, 4, 6, or 8 weeks after treatment, 10 rats in control group and 5 rats in experimental group were sacrificed. The lung tissues were collected for conventional pathological observation. The protein expression of Prx I at each time point was measured by immunohistochemistry and Western blot.</p><p><b>RESULTS</b>Among the rats exposed to silica dust, Prx I was seen in the form of brown particles that were mainly distributed in the alveolar septa and the cytoplasm of alveolar epithelial cells, macrophages, vascular endothelial cells, and smooth muscle cells around the blood vessels and tracheae. The control group showed weak protein expression of Prx I, and the experimental group had significantly higher protein expression of Prx I than the control group at all time points (P < 0.05). In the experimental group, the protein expression of Prx I was upregulated significantly at 1 and 2 weeks and decreased at 3∼8 weeks.</p><p><b>CONCLUSION</b>The change in protein expression of Prx I may be one of the important causes of the onset and development of pulmonary fibrosis in rats exposed to free silica.</p>


Subject(s)
Animals , Male , Rats , Disease Models, Animal , Lung , Pathology , Peroxiredoxins , Metabolism , Pulmonary Fibrosis , Pathology , Rats, Wistar , Silicon Dioxide , Toxicity , Silicosis , Pathology
20.
Journal of Southern Medical University ; (12): 1255-1259, 2012.
Article in Chinese | WPRIM | ID: wpr-315489

ABSTRACT

<p><b>OBJECTIVE</b>To characterize the expressions of peroxiredoxin 1 (Prx1), peroxiredoxin 6 (Prx6) and glial fibrillary acidic protein (GFAP) in human brain astrocytoma and explore their clinical significance.</p><p><b>METHODS</b>The protein and mRNA expression levels of Prx1, Prx6 and GFAP in human brain astrocytoma and normal brain tissue specimens were determined by Western blotting, RT-PCR and immunohistochemistry.</p><p><b>RESULTS</b>The protein and mRNA expressions of Prx1 and Prx6 increased significantly in the order of normal brain tissue, grade II astrocytoma, grade III astrocytoma and grade IV astrocytoma (P<0.05). The protein and mRNA expressions of GFAP decreased significantly in grade III and IV astrocytoma compared with those in grade II astrocytoma and normal brain tissues (P<0.05).</p><p><b>CONCLUSION</b>Prx1 and Prx6 may play important roles in the invasion and malignant development of human brain astrocytoma, and may serve as biomarkers for evaluating the invasiveness, malignancy and prognosis of the tumor as well as potential molecular targets in astrocytoma therapy.</p>


Subject(s)
Adolescent , Adult , Aged , Child , Child, Preschool , Female , Humans , Male , Middle Aged , Young Adult , Astrocytoma , Metabolism , Pathology , Brain Neoplasms , Metabolism , Pathology , Glial Fibrillary Acidic Protein , Metabolism , Peroxiredoxin VI , Metabolism , Peroxiredoxins , Metabolism
SELECTION OF CITATIONS
SEARCH DETAIL